All-Oral Combination of Revumenib, Decitabine, and Venetoclax for Relapsed or Refractory AML (SAVE)

Ghayas C. Issa, Branko Cuglievan, Georgina El Hajjar, Wei Ying Jen, Alex Bataller, Nicholas J. Short, Courtney D. DiNardo, Yesid Alvarado, Sanam Loghavi, Dzifa Yawa Duose, Baili Zhang, Ken Furudate, Jing Ning, Lianchun Xiao, Elie Mouhayar, Alessandro Pinto, Aram Bidikian, Erika Thompson, Naval Daver, Guillermo Garcia-Manero, Aziz Farhat, David McCall, Tapan M. Kadia, Hussein A. Abbas, Sheila Tan, Alexandre Bazinet, Elias Jabbour, Guillermo Montalban-Bravo, Farhad Ravandi, Koichi Takahashi, Michael Andreeff, Hagop M. Kantarjian

Open source

DOI: 10.1200/jco-26-01159
Published: 2026-08-01
Container: Journal of Clinical Oncology
Publisher: American Society of Clinical Oncology (ASCO)
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1200/jco-26-01159,
  title = {All-Oral Combination of Revumenib, Decitabine, and Venetoclax for Relapsed or Refractory AML (SAVE)},
  author = {Ghayas C. Issa and Branko Cuglievan and Georgina El Hajjar and Wei Ying Jen and Alex Bataller and Nicholas J. Short and Courtney D. DiNardo and Yesid Alvarado and Sanam Loghavi and Dzifa Yawa Duose and Baili Zhang and Ken Furudate and Jing Ning and Lianchun Xiao and Elie Mouhayar and Alessandro Pinto and Aram Bidikian and Erika Thompson and Naval Daver and Guillermo Garcia-Manero and Aziz Farhat and David McCall and Tapan M. Kadia and Hussein A. Abbas and Sheila Tan and Alexandre Bazinet and Elias Jabbour and Guillermo Montalban-Bravo and Farhad Ravandi and Koichi Takahashi and Michael Andreeff and Hagop M. Kantarjian},
  year = {2026},
  journal = {Journal of Clinical Oncology},
  doi = {10.1200/jco-26-01159},
  url = {https://doi.org/10.1200/jco-26-01159}
}

RIS

TY  - JOUR
TI  - All-Oral Combination of Revumenib, Decitabine, and Venetoclax for Relapsed or Refractory AML (SAVE)
AU  - Ghayas C. Issa
AU  - Branko Cuglievan
AU  - Georgina El Hajjar
AU  - Wei Ying Jen
AU  - Alex Bataller
AU  - Nicholas J. Short
AU  - Courtney D. DiNardo
AU  - Yesid Alvarado
AU  - Sanam Loghavi
AU  - Dzifa Yawa Duose
AU  - Baili Zhang
AU  - Ken Furudate
AU  - Jing Ning
AU  - Lianchun Xiao
AU  - Elie Mouhayar
AU  - Alessandro Pinto
AU  - Aram Bidikian
AU  - Erika Thompson
AU  - Naval Daver
AU  - Guillermo Garcia-Manero
AU  - Aziz Farhat
AU  - David McCall
AU  - Tapan M. Kadia
AU  - Hussein A. Abbas
AU  - Sheila Tan
AU  - Alexandre Bazinet
AU  - Elias Jabbour
AU  - Guillermo Montalban-Bravo
AU  - Farhad Ravandi
AU  - Koichi Takahashi
AU  - Michael Andreeff
AU  - Hagop M. Kantarjian
PY  - 2026
JO  - Journal of Clinical Oncology
DO  - 10.1200/jco-26-01159
UR  - https://doi.org/10.1200/jco-26-01159
ER  -

APA

Issa, G. C., Cuglievan, B., Hajjar, G. E., Jen, W. Y., Bataller, A., Short, N. J., DiNardo, C. D., Alvarado, Y., Loghavi, S., Duose, D. Y., Zhang, B., Furudate, K., Ning, J., Xiao, L., Mouhayar, E., Pinto, A., Bidikian, A., Thompson, E., Daver, N., Garcia-Manero, G., Farhat, A., McCall, D., Kadia, T. M., Abbas, H. A., Tan, S., Bazinet, A., Jabbour, E., Montalban-Bravo, G., Ravandi, F., Takahashi, K., Andreeff, M., & Kantarjian, H. M. (2026). All-Oral Combination of Revumenib, Decitabine, and Venetoclax for Relapsed or Refractory AML (SAVE). Journal of Clinical Oncology. https://doi.org/10.1200/jco-26-01159

Source records

crossref · retrieved 2026-09-26T06:54:25.430Z